name,category,termsBardet-Biedl syndrome 1,OMIM_DISEASE[520000507$Bardet-Biedl syndrome 1]
Bardet-Biedl syndrome 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000168$Bardet-Biedl syndrome, 790000264$cell membrane, 790000267$cell projection, 790000321$cilium, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000919$membrane, 790001067$obesity, 790001162$phosphoprotein, 790001377$sensory transduction, 790001622$vision]
Bardet-Biedl syndrome 1,UP_SEQ_FEATURE[850007298$chain:Bardet-Biedl syndrome 1 protein, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
DNA fragmentation factor, 45kDa, alpha polypeptide,BIOCARTA[30000048$h_caspasePathway:Caspase Cascade in Apoptosis, 30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors , 30000084$h_DNAfragmentPathway:Apoptotic DNA fragmentation and tissue homeostasis, 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000188$h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling, 30000268$h_setPathway:Granzyme A mediated Apoptosis Pathway, 30000297$h_tnfr1Pathway:TNFR1 Signaling Pathway]
DNA fragmentation factor, 45kDa, alpha polypeptide,INTERPRO[450003076$IPR003508:Caspase-activated nuclease CIDE-N, 450013568$IPR015121:DNA fragmentation factor 45kDa, C-terminal, 450015622$IPR017299:DNA fragmentation factor, alpha subunit]
DNA fragmentation factor, 45kDa, alpha polypeptide,KEGG_PATHWAY[470038843$hsa04210:Apoptosis]
DNA fragmentation factor, 45kDa, alpha polypeptide,PIR_SUPERFAMILY[630029432$PIRSF037865:DFF_alpha, 630029433$PIRSF037865:DNA fragmentation factor, alpha subunit]
DNA fragmentation factor, 45kDa, alpha polypeptide,SMART[760000238$SM00266:CAD]
DNA fragmentation factor, 45kDa, alpha polypeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001162$phosphoprotein]
DNA fragmentation factor, 45kDa, alpha polypeptide,UP_SEQ_FEATURE[850015550$chain:DNA fragmentation factor subunit alpha, 850103367$domain:CIDE-N, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118020$site:Cleavage; by caspase-3, 850118574$splice variant, 850118575$strand, 850118624$turn]
KIAA1305,INTERPRO[450001406$IPR001584:Integrase, catalytic core]
KIAA1305,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000853$leucine-rich repeat, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
KIAA1305,UP_SEQ_FEATURE[850026221$chain:Integrase catalytic domain-containing protein KIAA1305, 850104419$domain:Integrase catalytic, 850106258$modified residue, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
RAS p21 protein activator 2,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450001388$IPR001562:Zinc finger, Btk motif, 450001635$IPR001849:Pleckstrin homology, 450001714$IPR001936:Ras GTPase-activating protein, 450010818$IPR011993:Pleckstrin homology-type, 450016334$IPR018029:C2 membrane targeting protein]
RAS p21 protein activator 2,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway]
RAS p21 protein activator 2,SMART[760000094$SM00107:BTK, 760000205$SM00233:PH, 760000211$SM00239:C2, 760000292$SM00323:RasGAP]
RAS p21 protein activator 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000640$GTPase activation, 790000937$metal-binding, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
RAS p21 protein activator 2,UP_SEQ_FEATURE[850056684$chain:Ras GTPase-activating protein 2, 850102378$compositionally biased region:Ala-rich, 850103200$domain:C2 1, 850103201$domain:C2 2, 850104979$domain:PH, 850105148$domain:Ras-GAP, 850106258$modified residue, 850117294$sequence conflict, 850118652$zinc finger region:Btk-type]
RUN and SH3 domain containing 2,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450003532$IPR004012:RUN, 450010373$IPR011511:Variant SH3]
RUN and SH3 domain containing 2,SMART[760000295$SM00326:SH3, 760000527$SM00593:RUN]
RUN and SH3 domain containing 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
RUN and SH3 domain containing 2,UP_SEQ_FEATURE[850026732$chain:Iporin, 850102572$compositionally biased region:Poly-Glu, 850105223$domain:RUN, 850105350$domain:SH3, 850106258$modified residue, 850117295$sequence variant]
UDP glucuronosyltransferase 2 family, polypeptide B15,INTERPRO[450001963$IPR002213:UDP-glucuronosyl/UDP-glucosyltransferase]
UDP glucuronosyltransferase 2 family, polypeptide B15,KEGG_PATHWAY[470038728$hsa00040:Pentose and glucuronate interconversions, 470038731$hsa00053:Ascorbate and aldarate metabolism, 470038739$hsa00140:Steroid hormone biosynthesis, 470038740$hsa00150:Androgen and estrogen metabolism, 470038765$hsa00500:Starch and sucrose metabolism, 470038801$hsa00830:Retinol metabolism, 470038802$hsa00860:Porphyrin and chlorophyll metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism, 470038810$hsa00983:Drug metabolism]
UDP glucuronosyltransferase 2 family, polypeptide B15,PIR_SUPERFAMILY[630005607$PIRSF005678:glucuronosyltransferase]
UDP glucuronosyltransferase 2 family, polypeptide B15,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000691$hexosyltransferase, 790000919$membrane, 790000959$microsome, 790001212$polymorphism, 790001405$signal, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein]
UDP glucuronosyltransferase 2 family, polypeptide B15,UP_SEQ_FEATURE[850068247$chain:UDP-glucuronosyltransferase 2B15, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118623$transmembrane region]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,BBID[10000004$101.Gprot_coupled_Rec_MAP_Kinase, 10000104$82.TCR_and_Cap_or_SMAC]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,BIOCARTA[30000008$h_agrPathway:Agrin in Postsynaptic Differentiation, 30000055$h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration, 30000179$h_malPathway:Role of MAL in Rho-Mediated Activation of SRF, 30000215$h_p38mapkPathway:p38 MAPK Signaling Pathway , 30000255$h_rasPathway:Ras Signaling Pathway, 30000265$h_salmonellaPathway:How does salmonella hijack a cell]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,INTERPRO[450001599$IPR001806:Ras GTPase, 450003145$IPR003578:Ras small GTPase, Rho type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038831$hsa04062:Chemokine signaling pathway, 470038841$hsa04144:Endocytosis, 470038851$hsa04360:Axon guidance, 470038852$hsa04370:VEGF signaling pathway, 470038853$hsa04510:Focal adhesion, 470038856$hsa04520:Adherens junction, 470038857$hsa04530:Tight junction, 470038869$hsa04660:T cell receptor signaling pathway, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038873$hsa04670:Leukocyte transendothelial migration, 470038877$hsa04722:Neurotrophin signaling pathway, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038883$hsa04912:GnRH signaling pathway, 470038897$hsa05120:Epithelial cell signaling in Helicobacter pylori infection, 470038898$hsa05130:Pathogenic Escherichia coli infection, 470038899$hsa05200:Pathways in cancer, 470038901$hsa05211:Renal cell carcinoma, 470038902$hsa05212:Pancreatic cancer]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,PIR_SUPERFAMILY[630028684$PIRSF037169:small GTPase, Rho type, 630030779$PIRSF500582:cell division control protein 42]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,SMART[760000148$SM00174:RHO]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000260$cell division, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000637$GTP binding, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000952$methylated carboxyl end, 790000953$methylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001235$prenylated cysteine, 790001236$prenylation]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,UP_SEQ_FEATURE[850010330$chain:Cell division control protein 42 homolog, 850105852$helix, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850109701$propeptide:Removed in mature form, 850117441$short sequence motif:Effector region, 850118574$splice variant, 850118575$strand, 850118624$turn]
dynactin 2 (p50),INTERPRO[450006392$IPR006996:Dynamitin]
dynactin 2 (p50),KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
dynactin 2 (p50),SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000475$dynein, 790000919$membrane, 790000960$microtubule, 790001162$phosphoprotein]
dynactin 2 (p50),UP_SEQ_FEATURE[850016477$chain:Dynactin subunit 2, 850106258$modified residue, 850117294$sequence conflict]
glial fibrillary acidic protein,BIOCARTA[30000239$h_prionPathway:Prion Pathway]
glial fibrillary acidic protein,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450006225$IPR006821:Intermediate filament, DNA-binding region, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
glial fibrillary acidic protein,OMIM_DISEASE[520000214$Alexander disease]
glial fibrillary acidic protein,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
glial fibrillary acidic protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000788$Intermediate filament, 790001162$phosphoprotein, 790001212$polymorphism]
glial fibrillary acidic protein,UP_SEQ_FEATURE[850021232$chain:Glial fibrillary acidic protein, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111277$region of interest:Coil 2A, 850111278$region of interest:Coil 2B, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850113286$region of interest:Linker 2, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),INTERPRO[450001972$IPR002225:3-beta hydroxysteroid dehydrogenase/isomerase, 450002724$IPR003100:Argonaute and Dicer protein, PAZ, 450002783$IPR003165:Stem cell self-renewal protein Piwi, 450014426$IPR016040:NAD(P)-binding domain]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),KEGG_PATHWAY[470038737$hsa00120:Primary bile acid biosynthesis, 470038847$hsa04320:Dorso-ventral axis formation]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),OMIM_DISEASE[520000990$Cholestasis, progressive familial intrahepatic 4]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),PIR_SUPERFAMILY[630028161$PIRSF036679:bifunctional 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase, 630029992$PIRSF038460:piwi protein]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000790$intrahepatic cholestasis, 790000915$meiosis, 790000919$membrane, 790000953$methylation, 790001006$nad, 790001077$oogenesis, 790001092$oxidoreductase, 790001212$polymorphism, 790001339$rna-binding, 790001342$rna-mediated gene silencing, 790001426$spermatogenesis, 790001444$steroidogenesis, 790001551$translation regulation, 790001555$transmembrane]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000454$binding site:NAD, 850001374$chain:3 beta-hydroxysteroid dehydrogenase type 7, 850039216$chain:Piwi-like protein 2, 850104911$domain:PAZ, 850105001$domain:Piwi, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
integral membrane protein 2A,INTERPRO[450006473$IPR007084:BRICHOS]
integral membrane protein 2A,OMIM_DISEASE[520003072$Many sequence variants affecting diversity of adult human height]
integral membrane protein 2A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001555$transmembrane]
integral membrane protein 2A,UP_SEQ_FEATURE[850026207$chain:Integral membrane protein 2A, 850103162$domain:BRICHOS, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118623$transmembrane region]
late cornified envelope 1C,INTERPRO[450002847$IPR003267:Small proline-rich]
late cornified envelope 1C,SP_PIR_KEYWORDS[790000356$complete proteome, 790000822$keratinization, 790001212$polymorphism]
late cornified envelope 1C,UP_SEQ_FEATURE[850028022$chain:Late cornified envelope protein 1C, 850102517$compositionally biased region:Gly-rich, 850102586$compositionally biased region:Pro-rich, 850117295$sequence variant]
nudix (nucleoside diphosphate linked moiety X)-type motif 6,INTERPRO[450000072$IPR000086:NUDIX hydrolase domain, 450000073$IPR000086:NUDIX hydrolase, core, 450002872$IPR003293:Anti-sense to fibroblast growth factor protein GFG]
nudix (nucleoside diphosphate linked moiety X)-type motif 6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000811$isopeptide bond, 790001212$polymorphism, 790001592$ubl conjugation]
nudix (nucleoside diphosphate linked moiety X)-type motif 6,UP_SEQ_FEATURE[850035299$chain:Nucleoside diphosphate-linked moiety X motif 6, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850104864$domain:Nudix hydrolase, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117628$short sequence motif:Nudix box, 850118574$splice variant, 850118575$strand, 850118624$turn]
peptidyl-tRNA hydrolase 2,INTERPRO[450002507$IPR002833:Peptidyl-tRNA hydrolase, PTH2]
peptidyl-tRNA hydrolase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000109$Apoptosis, 790000356$complete proteome, 790000743$hydrolase, 790000969$mitochondrion, 790001162$phosphoprotein, 790001550$transit peptide]
peptidyl-tRNA hydrolase 2,UP_SEQ_FEATURE[850037694$chain:Peptidyl-tRNA hydrolase 2, mitochondrial, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118617$transit peptide:Mitochondrion]
pleckstrin homology domain interacting protein,INTERPRO[450001324$IPR001487:Bromodomain, 450001490$IPR001680:WD40 repeat, 450010012$IPR011042:Six-bladed beta-propeller, TolB-like, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450016644$IPR018359:Bromodomain, conserved site, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
pleckstrin homology domain interacting protein,SMART[760000267$SM00297:BROMO, 760000289$SM00320:WD40]
pleckstrin homology domain interacting protein,SP_PIR_KEYWORDS[790000012$acetylation, 790000206$bromodomain, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
pleckstrin homology domain interacting protein,UP_SEQ_FEATURE[850038065$chain:PH-interacting protein, 850102554$compositionally biased region:Lys-rich, 850102572$compositionally biased region:Poly-Glu, 850103167$domain:Bromo 1, 850103168$domain:Bromo 2, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117294$sequence conflict, 850117295$sequence variant]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),BIOCARTA[30000110$h_fasPathway:FAS signaling pathway ( CD95 )]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000257$IPR000299:FERM domain, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450001316$IPR001478:PDZ/DHR/GLGF, 450010003$IPR011019:KIND, 450010818$IPR011993:Pleckstrin homology-type, 450010931$IPR012153:Protein-tyrosine phosphatase, non-receptor type-13, 450012944$IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle, 450014489$IPR016130:Protein-tyrosine phosphatase, active site, 450017249$IPR018979:FERM, N-terminal, 450017250$IPR018980:FERM, C-terminal PH-like domain, 450017984$IPR019747:FERM conserved site, 450017985$IPR019748:FERM central domain, 450017986$IPR019749:Band 4.1 domain, 450017987$IPR019750:Band 4.1 subgroup]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),PIR_SUPERFAMILY[630001080$PIRSF000933:non-receptor tyrosine-protein phosphatase, type 13, 630001081$PIRSF000933:Tyr-Ptase_nr13]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),SMART[760000168$SM00194:PTPc, 760000200$SM00228:PDZ, 760000266$SM00295:B41, 760000656$SM00750:KIND]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000743$hydrolase, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001261$protein phosphatase, 790001301$receptor, 790001304$repeat, 790001587$tyrosine-specific phosphatase]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850067649$chain:Tyrosine-protein phosphatase non-receptor type 13, 850102576$compositionally biased region:Poly-Leu, 850102581$compositionally biased region:Poly-Ser, 850103760$domain:FERM, 850104540$domain:KIND, 850104919$domain:PDZ 1, 850104924$domain:PDZ 2, 850104925$domain:PDZ 3, 850104926$domain:PDZ 4, 850104927$domain:PDZ 5, 850105593$domain:Tyrosine-protein phosphatase, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
signal sequence receptor, beta (translocon-associated protein beta),INTERPRO[450008099$IPR008856:Translocon-associated beta]
signal sequence receptor, beta (translocon-associated protein beta),PIR_SUPERFAMILY[630013173$PIRSF016400:translocon-associated protein, beta subunit, 630013174$PIRSF016400:TRAP_beta]
signal sequence receptor, beta (translocon-associated protein beta),SP_PIR_KEYWORDS[790000356$complete proteome, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
signal sequence receptor, beta (translocon-associated protein beta),UP_SEQ_FEATURE[850065890$chain:Translocon-associated protein subunit beta, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
spermatid associated,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
spermatid associated,UP_SEQ_FEATURE[850061868$chain:Spermatid-associated protein, 850117295$sequence variant, 850118574$splice variant]
splA/ryanodine receptor domain and SOCS box containing 3,INTERPRO[450001330$IPR001496:SOCS protein, C-terminal, 450001654$IPR001870:B302 (SPRY)-like, 450003405$IPR003877:SPla/RYanodine receptor SPRY]
splA/ryanodine receptor domain and SOCS box containing 3,SMART[760000225$SM00253:SOCS]
splA/ryanodine receptor domain and SOCS box containing 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001301$receptor]
splA/ryanodine receptor domain and SOCS box containing 3,UP_SEQ_FEATURE[850062257$chain:SPRY domain-containing SOCS box protein 3, 850103078$domain:B30.2/SPRY, 850105375$domain:SOCS box, 850117294$sequence conflict, 850117295$sequence variant]
tetraspanin 16,BBID[10000086$66.Prot_Interac_w_integrin_domains]
tetraspanin 16,INTERPRO[450000259$IPR000301:Tetraspanin, subgroup, 450016772$IPR018499:Tetraspanin, 450016776$IPR018503:Tetraspanin, conserved site]
tetraspanin 16,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
tetraspanin 16,UP_SEQ_FEATURE[850063977$chain:Tetraspanin-16, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
vav 3 guanine nucleotide exchange factor,INTERPRO[450000189$IPR000219:Dbl homology (DH) domain, 450000852$IPR000980:SH2 motif, 450001173$IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site, 450001294$IPR001452:Src homology-3 domain, 450001520$IPR001715:Calponin-like actin-binding, 450001635$IPR001849:Pleckstrin homology, 450001967$IPR002219:Protein kinase C, phorbol ester/diacylglycerol binding, 450001968$IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding, 450002721$IPR003096:SM22/calponin, 450010373$IPR011511:Variant SH3, 450010818$IPR011993:Pleckstrin homology-type]
vav 3 guanine nucleotide exchange factor,KEGG_PATHWAY[470038831$hsa04062:Chemokine signaling pathway, 470038853$hsa04510:Focal adhesion, 470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038869$hsa04660:T cell receptor signaling pathway, 470038870$hsa04662:B cell receptor signaling pathway, 470038871$hsa04664:Fc epsilon RI signaling pathway, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038873$hsa04670:Leukocyte transendothelial migration, 470038881$hsa04810:Regulation of actin cytoskeleton]
vav 3 guanine nucleotide exchange factor,PIR_SUPERFAMILY[630001877$PIRSF001739:vav transforming protein]
vav 3 guanine nucleotide exchange factor,SMART[760000025$SM00033:CH, 760000096$SM00109:C1, 760000205$SM00233:PH, 760000224$SM00252:SH2, 760000294$SM00325:RhoGEF, 760000295$SM00326:SH3]
vav 3 guanine nucleotide exchange factor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000081$angiogenesis, 790000356$complete proteome, 790000641$guanine-nucleotide releasing factor, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001397$SH2 domain, 790001398$sh3 domain, 790001648$zinc, 790001651$zinc-finger]
vav 3 guanine nucleotide exchange factor,UP_SEQ_FEATURE[850022694$chain:Guanine nucleotide exchange factor VAV3, 850103317$domain:CH, 850103518$domain:DH, 850104979$domain:PH, 850105346$domain:SH2, 850105351$domain:SH3 1, 850105353$domain:SH3 2, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118624$turn, 850118892$zinc finger region:Phorbol-ester/DAG-type]
villin 1,INTERPRO[450002752$IPR003128:Villin headpiece, 450006496$IPR007122:Gelsolin, 450006497$IPR007123:Gelsolin region, 450014064$IPR015627:Villin]
villin 1,OMIM_DISEASE[520000986$Cholestasis, progressive canalicular]
villin 1,PIR_SUPERFAMILY[630002466$PIRSF002347:villin]
villin 1,SMART[760000135$SM00153:VHP, 760000234$SM00262:GEL]
villin 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000017$actin binding, 790000018$actin capping, 790000019$actin-binding, 790000211$calcium, 790000212$calcium binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000473$duplication, 790001212$polymorphism, 790001304$repeat]
villin 1,UP_SEQ_FEATURE[850100309$chain:Villin-1, 850104146$domain:HP, 850105852$helix, 850111307$region of interest:Core, 850111840$region of interest:Headpiece, 850114078$region of interest:Polyphosphoinositide binding, 850116060$repeat:Gelsolin-like 1, 850116061$repeat:Gelsolin-like 2, 850116062$repeat:Gelsolin-like 3, 850116063$repeat:Gelsolin-like 4, 850116064$repeat:Gelsolin-like 5, 850116065$repeat:Gelsolin-like 6, 850117294$sequence conflict, 850117295$sequence variant]
